Manufacturers of ablation and other energy-base therapeutics are both witnessing and driving a steady evolution of multiple technologies with potential to produce therapeutic (or, in some cases, simply cosmetic) tissue effects, with different energy types competing head-on for caseload. These innovators have continued to improve their understanding of the nature of each energy type’s impact [...]
[See Report #G125] There are four opportunities for significant growth in the ophthalmic medical device arena – each focusing on improving therapeutic outcomes. These include (1) Refractive Surgery, (2) Glaucoma, (2) Cataract Surgery, and (4) Management of Retinal Disorders. The drivers for each of these segments overlap in certain areas – aging demographics, increased consumer [...]
The following is an excerpt from the report, "Products, Technologies, Markets and Opportunities in Ophthalmology Surgical, Device and Drug Markets Worldwide, 2007," Report #G125, from MedMarket Diligence. Although a fair amount of consolidation has taken place among ophthalmology technology companies in the last half decade, a number of entrepreneurial firms have surfaced with promising innovations [...]
Contact:
